- UPL Ltd. is the world’s largest post-patent agricultural solutions company, built over five decades from a single factory in Gujarat into a global operation that reaches more than 140 countries and 18 million farmers. It began in 1969 making red phosphorus as an import substitute, then expanded through over 40 acquisitions - capped by the $4.2 billion purchase of Arysta LifeScience in 2019 - to become one of the top five crop protection companies worldwide. The recurring approach is to buy or build manufacturing scale in complex chemistries, then use that cost advantage to sell a wide portfolio of off-patent and differentiated products closer to the farmer than rivals do.
Business segments
Four engines at different stages - a global crop protection platform that generates the bulk of revenue, an India business that dominates its home market, a seeds and post-harvest unit headed for a public listing, and a specialty chemicals manufacturer that supplies both the group and outside customers - each carved out as a standalone company with its own CEO and investors.
1. Global Crop Protection - UPL Corp: the group’s main engine, selling off-patent and biological products in over 140 countries
It is the sixth-largest agrochemical company globally and the foremost provider of post-patent crop protection, with more than 60% of revenue coming from emerging markets and a growing share from differentiated, higher-margin products.
- Post-patent is the growth pool - the off-patent segment of the global crop protection market expanded from 59% in 2011 to 78% in 2024 and is expected to reach 82% by 2029, so UPL Corp’s core market is structurally gaining share from patented products.
- A portfolio that spans the field - herbicides make up 35% of the crop protection business, fungicides 25%, insecticides and acaricides 24%, and BioSolutions 11%, with over 2,000 products and more than 15,000 registrations worldwide.
- Differentiated, not just generic - 38% of UPL Corp’s revenue in FY25 came from differentiated and sustainable products, up three percentage points year-on-year, and the innovation rate - sales from products launched in the last five years - reached roughly 16% in FY26 with a target of over 20% by FY30.
- BioSolutions at scale - its Natural Plant Protection unit is the world’s largest manufacturer and distributor of BioSolutions, with nine manufacturing plants and brands like Vacciplant (a plant vaccine) and GAXY (a patented bio-stimulant) that carry higher contribution margins than conventional chemicals.
- Closer to the farmer - the go-to-market strategy focuses on demand generation and sell-out rather than pushing inventory into distribution channels, supported by an AI-powered demand forecasting engine and digital dealer tools across 26 formulation facilities and 57 R&D centres.
2. India Crop Protection - UPL SAS: the domestic champion with a 13% market share and a digital farmer network
It is India’s largest crop protection company, reaching farmers through 25,000 dealers and a digital platform that has onboarded over three million farmers, with 40% of sales already coming from differentiated and sustainable products.
- Coverage across the crop map - the portfolio covers more than 90% of crop types grown in India, with herbicides at 39% of sales, insecticides at 35%, fungicides at 16%, and BioSolutions at 4%, serving key crops like corn, rice, sugarcane and cotton.
- A digital bridge to the farm - the nurture.farm app provides mechanised spraying, harvesting, farm advisory and soil testing, while nurture.farm retail operates an e-commerce marketplace connecting over 100,000 retailers directly with manufacturers, with the overall Nurture AgTech platform achieving gross merchandise value of more than ₹200 crore in FY25.
- Manufacturing sits upstream - UPL SAS sources its agrochemical products from UPL Limited under a long-term supply arrangement priced at cost of goods sold plus a 10% margin, while the 13 manufacturing plants in India remain part of the parent company.
- Institutional backing - marquee investors ADIA, TPG and Brookfield invested $200 million for a 9.1% stake, giving the platform its own capital base and board oversight separate from the global business.
3. Seeds and Post-Harvest - Advanta: a top-10 global seed company paired with a fruit-preservation business, headed for a public listing
Advanta sells hybrid seeds across more than 60 crops in over 80 countries and runs one of the world’s largest post-harvest businesses, which treats nearly nine million tonnes of citrus fruit each year - and it has filed for an IPO.
- Bred for specific traits - proprietary technologies include ‘igrowth’, the world’s first commercial herbicide-tolerant sorghum, and ‘aphix’, which gives sorghum high-level tolerance to sugarcane aphid, alongside multivirus okra tolerance packages and corn genetics optimised for ethanol production.
- R&D that refreshes the shelf - the innovation rate, measured as sales from products launched in the last five years, improved to 33% in FY22 from 24% the year before, driven by a network of 31 research centres across 11 countries and over 70 plant research scientists.
- Valued by outside investors - KKR invested $300 million for a 13.33% stake at a $2.25 billion valuation, and Alpha Wave Global later acquired a 12.5% stake at a $2.8 billion valuation, with a draft IPO prospectus filed in January 2026.
4. Specialty Chemicals - SUPERFORM: the manufacturing backbone that supplies both the group and 600 external industrial customers
It is the group’s vertically integrated chemical factory, built on hard-to-replicate positions in phosphorus, cyanide, phosgene and acrolein chemistries, and it sells active ingredients to UPL Corp and UPL SAS while exporting over ₹1,000 crore of super-specialty chemicals to outside clients.
- Positions no rival can easily copy - SUPERFORM is the largest handler of phosphorus and phosphorus derivatives in India, the largest player in cyanidation and phosgenation for specialty chemistries, and the only producer of acrolein in the country, giving it a cost and supply advantage across agrochemicals, flame retardants, pharma and paints.
- Two revenue streams, one factory floor - the Active Ingredients sub-segment supplies UPL Corp and UPL SAS, while the Super Specialty Chemicals sub-segment sells externally to industries as varied as lubricants, mining, food and beverages, and personal care, with over 20 years of contract manufacturing experience for global players.
- Complex chemistries as a moat - the platform operates 12 technical plants with expertise in Grignard reaction, nitration, chlorination, hydrogenation and other difficult processes, supported by an integrated chemical complex with two dedicated pharma intermediate sites.
- Riding the China-plus-one shift - SUPERFORM is positioned to capture demand from global manufacturers looking to diversify away from China, aligned with India’s “Make in India” push, and is expanding capacity in phosphorus, phosgene, cyanation and sulphur chemistries.
Group structure and partners
UPL Ltd. has reorganised into four pure-play platforms - each with its own CEO, board and external investors - and is now splitting into two listed entities to separate the crop protection business from the diversified agro-chemical parent.
- A two-company future - a composite scheme of arrangement approved in February 2026 will create UPL Ltd. as a diversified agro and specialty chemical platform that incubates new businesses, and UPL Global Sustainable Agri Solutions Ltd. as a dedicated listed crop protection company, with Mike Frank appointed as CEO of the new entity.
- Joint ventures that extend reach - the 50:50 Origeo joint venture with Bunge in Brazil offers farmers integrated inputs, services and financing; the Sinova associate in Brazil (55.81% stake) resells grains and agricultural products in the Cerrado region; and the Augene Chemical joint venture with Aarti Industries manufactures specialty chemicals for agrochemical and paint applications.
- Strategic collaborations fill the pipeline - long-term agreements with FMC for the Rynaxypyr insecticide active ingredient, with Meiji Seika Pharma for the novel Flupyrimin insecticide, with Chr. Hansen for microbial biosolutions, and with CAC Nantong for cyproflanilide products give UPL access to patented molecules and biologicals it can commercialise through its global distribution network.